Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20060030885 A1
Publication typeApplication
Application numberUS 11/240,589
Publication dateFeb 9, 2006
Filing dateSep 29, 2005
Priority dateOct 15, 2002
Also published asUS7087064, US7740638, US8133272, US20070050019, US20100222876
Publication number11240589, 240589, US 2006/0030885 A1, US 2006/030885 A1, US 20060030885 A1, US 20060030885A1, US 2006030885 A1, US 2006030885A1, US-A1-20060030885, US-A1-2006030885, US2006/0030885A1, US2006/030885A1, US20060030885 A1, US20060030885A1, US2006030885 A1, US2006030885A1
InventorsGregory Hyde
Original AssigneeHyde Gregory M
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Apparatuses and methods for heart valve repair
US 20060030885 A1
Abstract
A medical device for treating a heart having a faulty heart valve is disclosed. The medical device comprises a ligature including a first anchoring member and a second anchoring member is used. The ligature is percutaneously deployable into a patient with a faulty heart valve wherein the first anchoring member to anchor to a first tissue area of the heart and the second anchoring member to anchor to a second tissue area of the heart.
Images(17)
Previous page
Next page
Claims(37)
1-8. (canceled)
9. A medical device comprising:
a delivery shaft having a delivery lumen, a proximal end, and a distal end;
a first deployment shaft disposed within said delivery lumen and extending from said proximal end to said distal end;
a second deployment shaft disposed within said delivery lumen and extending from said proximal end to said distal end;
a ligature having a first anchoring member and a second anchoring member is releasably coupled to said delivery shaft;
said delivery shaft to deploy said ligature into a patient wherein said first deployment shaft to deploy said first anchoring member to a first tissue area of said patient and said second deployment shaft to deploy said second anchoring member to a second tissue area of said patient.
10. The medical device as in claim 9 further comprises a delivery handle coupling to said delivery shaft at said proximal end, said delivery handle further comprises a first deployment mechanism and a second deployment mechanism wherein said first deployment mechanism deploys said first anchoring member to said first tissue area and said second deployment mechanism deploys said second anchoring member to said second tissue area.
11. The medical device as in claim 10 wherein said delivery handle further comprises a first rotating mechanism and a second rotating mechanism wherein said first rotating mechanism deploys rotates said first anchoring member to pierce said first anchoring member into said first tissue area and said second rotating mechanism rotates said second anchoring member to pierce said second anchoring member into said second tissue area.
12. The medical device as in claim 9 wherein said delivery shaft is pre-shaped to allow said delivery shaft to be maneuvered to an area within said patient.
13. The medical device as in claim 9 further comprises a guidewire disposed within said delivery shaft to guide said delivery shaft to an area within said patient.
14. The medical device as in claim 9 further wherein said delivery shaft further comprises a first deployment lumen, a second deployment lumen, and a guidewire lumen wherein said first deployment shaft is disposed within said first deployment lumen, said second deployment shaft is disposed within said second deployment lumen, and said guidewire is disposed within said guidewire lumen.
15. The medical device as in claim 9 wherein said delivery shaft further comprises a lumen that is to be pressurized to facilitate maneuvering of said delivery shaft.
16. The medical device as in claim 9 further comprises a support member disposed within said delivery shaft extending from said distal end to said proximal end, said support member having a shape that curves said delivery shaft to facilitate maneuvering of said delivery shaft.
17. The medical device as in claim 9 wherein said first anchoring member and said second anchoring member have configurations of one of a barbed end, a helical end, and a hooked end.
18. The medical device as in claim 9 wherein said ligature is made from one of an elastomeric material, a superelastic material, a flexible material, a shape memory material, and a rigid material.
19. The medical device as in claim 9 wherein said ligature is made out of a stretchable material.
20. The medical device as in claim 19 wherein during deployment, said ligature is stretched and after said deployment, said ligature is returned to an unstretched length.
21. The medical device as in claim 9 wherein said ligature has a cross section size sufficiently small to not significantly impede a blood flow through an area where said ligature is anchored across.
22. The medical device as in claim 9 wherein said ligature is placed across a heart valve to constrict said heart valve, said ligature to have a cross section size sufficiently small to not significantly impede a blood flow through said heart valve.
23. The medical device as in claim 22 wherein said heart valve is a mitral valve.
24. A method of constricting a heart valve of a patient comprising:
providing a medical device comprising a delivery shaft having a delivery lumen, a proximal end, and a distal end, said delivery shaft further comprises a first deployment shaft and a second deployment shaft disposed within said delivery lumen, said delivery shaft further comprises a ligature releasably coupled thereto, said ligature having a first anchoring member and a second anchoring member; and
deploying said ligature into said patient wherein said first deployment shaft deploys said first anchoring member to a first tissue area around said heart valve and said second deployment shaft deploys said second anchoring member to a second tissue area of said heart valve, and wherein said deploying anchors said first anchoring member to said first tissue area and said second anchoring member to said second tissue area.
25. The method of claim 24 wherein said first tissue area and said second tissue area are substantially opposite from each other.
26. The method as in claim 24 said delivery shaft is further coupled to a delivery handle having a first deployment mechanism and a second deployment mechanism wherein said first deployment mechanism deploys said first anchoring member and said second deployment mechanism deploys said second anchoring member.
27. The method as in claim 26 wherein said delivery handle further comprises a first rotating mechanism and a second rotating mechanism wherein said first rotating mechanism deploys rotates said first anchoring member to pierce said first anchoring member into said first tissue area and said second rotating mechanism rotates said second anchoring member to pierce said second anchoring member into said second tissue area.
28. The method as in claim 24 wherein said first anchoring member and said second anchoring member have configurations of one of a barbed end, a helical end, and a hooked end.
29. The method as in claim 24 wherein said ligature is made from one of an elastomeric material, a superelastic material, a flexible material, a shape memory material, and a rigid material.
30. The method as in claim 24 wherein said ligature is made out of a stretchable material.
31. The method as in claim 30 wherein said ligature is returnable to said first length after said first anchoring member is anchored to said first tissue area and said second anchoring member is anchored to said second tissue area.
32. The method as in claim 24 wherein said ligature has a cross section size sufficiently small to not significantly impede a blood flow through said heart valve when said ligature is anchored across said heart valve.
33. The method as in claim 24 wherein said heart valve is a mitral valve.
34. The method as in claim 24 wherein said ligature is deployed percutaneously into said patient wherein said ligature is deployed though a blood vessel.
35. A method of constricting a heart valve of a patient comprising:
providing a medical device comprising a delivery shaft having a delivery lumen, a proximal end, and a distal end, said delivery shaft further comprises a first deployment shaft and a second deployment shaft disposed within said delivery lumen;
coupling a first ligature to said delivery shaft and deploying said first ligature to a heart valve area of said patient;
coupling a second ligature to said delivery shaft and deploying said second ligature to said heart valve area of said patient;
wherein each ligature of said first ligature and second ligature has a first anchoring member and a second anchoring member;
wherein said first deployment shaft deploys said first anchoring member to anchor said first anchoring member to said heart valve area to constrict said heart valve, said second deployment shaft deploys said second anchoring member to anchor said second anchoring member to said heart valve area to constrict said heart valve.
36. The method of claim 35 wherein said delivery shaft deploys said first ligature and said second ligature sequentially.
37. The method of claim 35 wherein said first anchoring member of each of said first ligature and said second ligature is anchored to a tissue area around said heart valve that is opposite from another tissue area around said heart valve where said second anchoring member of each of said first ligature and said second ligature is anchored to.
38. The method of claim 37 wherein said first ligature and said second ligature are parallel to one another after said first ligature and said second ligature are deployed and anchored to said heart valve.
39. The method of claim 37 wherein said first ligature and said second ligature are intersect one another after said first ligature and said second ligature are deployed and anchored to said heart valve.
40. The method as in claim 35 wherein said first ligature and said second ligature are deployed percutaneously into said patient wherein said first ligature and said second ligature are deployed though blood vessels.
41. A method of constricting a ventricle of a patient comprising:
providing a medical device comprising a delivery shaft having a delivery lumen, a proximal end, and a distal end, said delivery shaft further comprises a first deployment shaft and a second deployment shaft disposed within said delivery lumen, said delivery shaft further comprises a ligature releasably coupled thereto, said ligature having a first anchoring member and a second anchoring member; and
deploying said ligature into the heart of said patient wherein said first deployment shaft deploys said first anchoring member to a first tissue area of said ventricle and said second deployment shaft deploys said second anchoring member to a second tissue area of said ventricle, wherein said deploying anchors said first anchoring member to said first tissue area and said second anchoring member to said second tissue area.
42. The method of claim 41 wherein said first tissue area is a papillary muscle of said ventricle and wherein said second tissue area is another papillary muscle of said ventricle that is substantially opposite said first tissue area.
43. The method as in claim 41 wherein said ligature is deployed percutaneously into said patient wherein said ligature is deployed though blood vessels.
44. A method of constricting a mitral valve of a patient comprising:
providing a medical device comprising a delivery shaft having a delivery lumen, a proximal end, and a distal end, said delivery shaft further comprises a first deployment shaft and a second deployment shaft disposed within said delivery lumen, said delivery shaft further comprises a ligature releasably coupled thereto, said ligature having a first anchoring member and a second anchoring member; and
deploying said ligature is within a coronary sinus that substantially encircles said mitral valve;
deploying said first anchoring member to a first tissue area around said mitral valve;
deploying said second anchoring member to a second tissue area around said mitral valve; wherein
said first deployment shaft deploys and anchors said first anchoring member to said first tissue area and said second deployment shaft deploys and anchors said second anchoring member to said second tissue area.
Description
    BACKGROUND OF THE INVENTION
  • [0001]
    1. Field of the Invention
  • [0002]
    The present invention involves a medical device that is used for treating a defective heart valve.
  • [0003]
    2. Discussion of Related Art
  • [0004]
    FIG. 1A illustrates a heart 10. There are four valves in the heart 10 that serve to direct the flow of blood through the two sides of the heart 10 in a forward direction. The four valves are a mitral valve 20, an aortic valve 18, a tricuspid valve 60, and a pulmonary valve 62 as illustrated in FIG. 1A. The mitral valve 20 is located between the left atrium 12 and the left ventricle 14. The aortic valve 18 is located between the left ventricle 14 and the aorta 16. These two valves direct oxygenated blood coming from the lungs, through the left side of the heart, into the aorta 16 for distribution to the body. The tricuspid valve 60 is located between the right atrium 22 and the right ventricle 24. The pulmonary valve 62 is located between the right ventricle 24 and the pulmonary artery 26. These two valves direct de-oxygenated blood coming from the body, through the right side of the heart, into the pulmonary artery 26 for distribution to the lungs, where it again becomes re-oxygenated and distributed to the mitral valve 20 and the aortic valve 18. All of the heart valves are complex structures. Each valve consists of moveable “leaflets” that are designed to open and close. The mitral valve has two leaflets and the tricuspid valve has three. The aortic and pulmonary valves have leaflets that are more aptly termed “cusps” and are shaped somewhat like a half-moon. The aortic and pulmonary valves each have three cusps.
  • [0005]
    Blood flows into the left ventricle 14 through the mitral valve 20 opens during diastole. Once the left ventricular cavity has filled, the left ventricle 14 contracts during systole. The mitral valve 20 closes (the leaflets of the mitral valve 20 re-approximate) while the aortic valve 18 opens during systole allowing the oxygenated blood to be ejected from the left ventricle 14 into the aorta 16. A normal mitral valve allows blood to flow into the left ventricle and does not allow leaking or regurgitating back into the left atrium and then into the lungs. The aortic valve allows blood to flow into the aorta and does not allow leaking (or regurgitating) back into the left ventricle. The tricuspid valve 60 functions similarly to the mitral valve to allow deoxygenated blood to flow into the right ventricle 24. The pulmonary valve 62 functions in the same manner as the aortic valve 18 in response to relaxation and contraction of the right ventricle 24 in moving de-oxygenated blood into the pulmonary artery and thence to the lungs for re-oxygenation.
  • [0006]
    With relaxation and expansion of the ventricles (diastole), the mitral and tricuspid valves open, while the aortic and pulmonary valves close. When the ventricles contract (systole), the mitral and tricuspid valves close and the aortic and pulmonary valves open. In this manner, blood is propelled through both sides of the heart.
  • [0007]
    The anatomy of the heart and the structure and terminology of heart valves are described and illustrated in detail in numerous reference works on anatomy and cardiac surgery, including standard texts such as Surgery of the Chest (Sabiston and Spencer, eds., Saunders Publ., Philadelphia) and Cardiac Surgery by Kirklin and Barrett-Boyes.
  • [0008]
    Regurgitation is a condition when leaflets of a heart valve do not completely close causing backflow of blood. For instance, in a condition typically called mitral valve prolapse, the leaflets of the mitral valve do not close properly and thus, there is backflow, or regurgitation, of blood into the left atrium and then into lungs. The heart then has to work harder to pump enough blood for the body, which can lead to heart damage. Regurgitation is common, and is occurring in about 7% of the population. Mitral valve regurgitation is caused by a number of conditions, including genetic defects, infections, coronary artery disease (CAD), myocardial infarction (MI) or congestive heart failure (CHF). Most cases are mild and if the symptoms are bothersome, they can usually be controlled with drugs.
  • [0009]
    In more serious cases, the faulty or defective valve can be repaired with a surgical procedure such as an annuloplasty. As illustrated in FIG. 1B, an annuloplasty 30 is a surgical procedure in which a synthetic ring 32 is placed around the valve rim (annulus) 34. Sutures 38 are put into the valve annulus 34 and the synthetic ring 32. This causes proper closing by shrinking the size of the valve opening 36. FIG. 1C illustrates another surgical procedure in which a heart valve such as the mitral valve 20 is repaired by reconstruction. First, at step A, a section P2 from the posterior leaflet 40 of the mitral valve 20 is excised. Then, sequentially at steps B, C, D, and E, sections P1 and P3 of the posterior leaflet 40 are sutured together. The reconstruction shrinks the size of the valve opening 36. In some instances, a faulty or defective valve must be surgically replaced with a new valve. Examples of new valves include homograft valves (valves harvested from human cadavers), artificial mitral valves, and mechanical valves.
  • [0010]
    All of the procedures above are typically major surgical procedures that require the opening of the chest by sternotomy or at best through small incisions in the chest wall, heart lung bypass and stopping the heart beat. These procedures are extremely invasive subjecting patients to a lot of pain and discomfort and these procedures require long recovery time and hospitalization time. In some instances, some patients may not tolerate surgery, for example, due to them having congestive heart failures. Thus, having alternative procedures as options to surgery is helpful.
  • SUMMARY OF THE INVENTION
  • [0011]
    The present invention discloses apparatuses and methods for treating a defective heart valve.
  • [0012]
    In one exemplary embodiment of the present invention, a medical device comprises a ligature, including a first anchoring member and a second anchoring member. The ligature is used to treat a hear having a faulty heart valve (e.g., a faulty mitral valve). The ligature is percutaneously deployable into a patient with a faulty heart valve, wherein the first anchoring member anchors to a first tissue area of the faulty heart valve and the second anchoring member anchors to a second tissue area of the faulty heart valve. The ligature constricts or reduces the size of the faulty heart valve.
  • [0013]
    In another exemplary embodiment of the present invention, a medical device comprises a delivery shaft having a delivery lumen, a proximal end, and a distal end. A first deployment shaft, extending from the proximal end to the distal end, is disposed within the delivery lumen. A second deployment shaft, extending from the proximal end to the distal end, is disposed within the delivery lumen. A ligature is releasably coupled to the delivery shaft. The ligature includes a first anchoring member and a second anchoring member. The delivery shaft deploys the ligature into a patient, wherein the first deployment shaft deploys the first anchoring member to a first tissue area of the patient, and the second deployment shaft deploys the second anchoring member to a second tissue area of the patient.
  • [0014]
    In another exemplary embodiment of the present invention, a method of constricting a heart valve of a patient comprises providing a medical device comprising a delivery shaft having a delivery lumen, a proximal end, and a distal end. The delivery shaft comprises a first deployment shaft and a second deployment shaft disposed within the delivery lumen. A ligature including a first anchoring member and a second anchoring member is releasably coupled to the delivery shaft wherein the first anchoring member is releasably coupled to the first deployment shaft and the second anchoring member is releasably coupled to the second deployment shaft. The method further comprises deploying the ligature into the patient wherein the first deployment shaft deploys the first anchoring member to a first tissue area around the heart valve, and the second deployment shaft deploys the second anchoring member to a second tissue area of the heart valve. Once deployed, the ligature anchors the first anchoring member to the first tissue area and the second anchoring member to the second tissue area.
  • [0015]
    In another exemplary embodiment of the present invention, a method of constricting a heart valve of a patient comprises providing a medical device comprising a delivery shaft having a delivery lumen, a proximal end, and a distal end. The delivery shaft comprises a first deployment shaft and a second deployment shaft disposed within the delivery lumen. The method further comprises coupling a first ligature to the delivery shaft and deploying the first ligature to a heart valve area of the patient and coupling a second ligature to the delivery shaft and deploying the second ligature to the heart valve area of the patient. Each of the ligatures includes a first anchoring member and a second anchoring member wherein the first anchoring member is releasably coupled to the first deployment shaft and the second anchoring member is releasably coupled to the second deployment shaft. The first deployment shaft deploys the first anchoring member to anchor the first anchoring member to the heart valve area to constrict the heart valve. The second deployment shaft deploys the second anchoring member to anchor the second anchoring member to the heart valve area to constrict the heart valve.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0016]
    The present invention is illustrated by way of example and not limitation in the figures of the accompanying drawings, in which like references indicate similar elements and in which:
  • [0017]
    FIG. 1A is an illustration of a heart;
  • [0018]
    FIG. 1B is an illustration of an annuloplasty procedure to constrict a defective valve;
  • [0019]
    FIG. 1C is an illustration of a reconstruction procedure to reduce the size of a defective valve;
  • [0020]
    FIG. 2A is an illustration of an exemplary embodiment of a ligature in accordance with the present invention;
  • [0021]
    FIG. 2B is an illustration of another exemplary embodiment of a ligature in accordance with the present invention;
  • [0022]
    FIG. 3 is an illustration of another exemplary embodiment of a ligature in accordance with the present invention;
  • [0023]
    FIG. 4 is an illustration of an exemplary embodiment of two ligatures being placed across a mitral valve in a parallel pattern to constrict the mitral valve in accordance with the present invention;
  • [0024]
    FIG. 5 is an illustration of another exemplary embodiment of two ligatures being placed across a mitral valve in an intersecting pattern to constrict the mitral valve in accordance with the present invention;
  • [0025]
    FIG. 6 is an illustration of an exemplary embodiment of a medical device that includes a delivery device which is used to percutaneously deploy a ligature into a patient to constrict a heart valve;
  • [0026]
    FIG. 7 is an illustration of a distal end of the medical device shown in FIG. 6 having a ligature disposed therein;
  • [0027]
    FIG. 8 is an illustration of a mid-section of the medical device shown in FIG. 6;
  • [0028]
    FIGS. 9-10 are illustrations of a perspective view of the medical device shown in FIG. 6 wherein a ligature is being deployed from the delivery shaft;
  • [0029]
    FIGS. 11A-11B illustrate another exemplary embodiment of a medical device that includes a delivery device which is used to percutaneously deploy a ligature into a patient to constrict a heart valve;
  • [0030]
    FIG. 12A is an illustration of an exemplary embodiment of a deployment shaft that can be used to deploy a ligature made in accordance with the present invention;
  • [0031]
    FIG. 12B is an illustration of an exemplary embodiment of the deployment shaft shown in FIG. 12A being disposed within a deployment lumen of a delivery device;
  • [0032]
    FIG. 12C is an illustration of an exemplary embodiment of a ligature with helix ends as anchoring members made in accordance with the present invention;
  • [0033]
    FIG. 12D is an illustration of an exemplary embodiment of the ligature shown in FIG. 12C being disposed within the deployment shaft shown in FIG. 12B;
  • [0034]
    FIG. 12E is an illustration of an exemplary embodiment of the ligature shown in FIG. 12C being disposed within the deployment shaft shown in FIG. 12B which is disposed within a deployment lumen of a delivery device;
  • [0035]
    FIGS. 12F-12G are illustrations of a distal end of the medical device shown in FIG. 6 with a ligature having helix ends as anchoring members;
  • [0036]
    FIGS. 13A-13H are illustrations of an exemplary embodiment of a method to deploy a ligature or ligatures in accordance with the present invention;
  • [0037]
    FIG. 14A is an illustration of an exemplary embodiment where a medical device made in accordance with the present invention can be inserted percutaneously into a patient to deploy a ligature to a heart valve area;
  • [0038]
    FIG. 14B is an illustration of another exemplary embodiment where a medical device made in accordance with the present invention can be inserted percutaneously into a patient to deploy a ligature to a heart valve area;
  • [0039]
    FIG. 14C is an illustration of an exemplary embodiment where a medical device made in accordance with the present invention can be inserted percutaneously into a patient to deploy a ligature to a ventricle area;
  • [0040]
    FIGS. 15A-15D are illustrations of an exemplary embodiment where a medical device made in accordance with the present invention can be inserted percutaneously into a coronary sinus; and
  • [0041]
    FIG. 16 is an illustration of an exemplary method of treating heart valve using medical devices made in according with the present invention.
  • DETAILED DESCRIPTION OF THE PRESENT INVENTION
  • [0042]
    The present invention pertains to novel medical devices and methods of using these medical devices to treat defective or faulty heart valves. In the following description, for purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of the present invention. It will be evident, however, to one skilled in the art, that the present invention may be practiced without these specific details. In other instances, specific apparatus structures and methods have not been described so as not to obscure the present invention. The following description and drawings are illustrative of the invention and are not to be construed as limiting the invention.
  • [0043]
    FIG. 2A illustrates an exemplary embodiment of a medical device that comprises a ligature 100. The ligature 100 can be a strap, string, cord, wire, bond, thread, suture, or other connector. The ligature 100 includes a first anchoring member 102A and a second anchoring member 102B. The ligature 100 serves to link together the first anchoring member 102A and the second anchoring member 102B. The ligature 100 can be percutaneously deployed into a patient with a faulty heart valve. By percutaneous deployment, the ligature 100 is deployed through blood vessels, veins, or arteries into a patient. In one embodiment, the ligature 100 is deployed through the blood vessels, veins, or arteries and into the heart area of a patient. The first anchoring member 102A and the second anchoring member 102B are then attached or anchored to a cardiac tissue (e.g., tissue around the heart valve). In one embodiment, the first anchoring member 102A and the second anchoring member 102B are not attached or anchored to a blood vessel, vein, or artery, and only attached or anchored to a cardiac tissue.
  • [0044]
    A faulty heart valve includes a heart valve that will not properly close causing backflow or regurgitation of blood. Such a faulty heart valve can be seen in a patient with a condition called regurgitation. In treating the faulty heart valve, the first anchoring member 102A anchors to a first tissue area of the faulty heart valve and the second anchoring member 102B anchors to a second tissue area of the faulty heart valve. The ligature 100 has a length that is sufficient to constrict or reduce the size of the heart valve once the anchoring members 102A and 102B are anchored into the tissue areas of the heart valve. Examples of a heart valve that can be treated with the ligature 100 include a mitral valve, an aortic valve, a tricuspid valve, and a pulmonary valve.
  • [0045]
    Although the ligature 100 is discussed in relation to treating a faulty heart valve, the ligature 100 may be used to treat other areas of a patient. For example, the ligature 100 can be used in ventricular remodeling to constrict, reshape, or reduce, the size of a left ventricle that has been enlarged due to some heart conditions. Alternatively, the ligature 100 can be used to close a vein or an artery of a patient.
  • [0046]
    The ligature 100 can be flexible or rigid. In one embodiment, the ligature 100 is made out of an elastic/resilient material, an elastomeric material, or a superelastic material. In one embodiment, the ligature 100 is made out of a superelastic nickel titanium, Nitinol, or stainless steel. In another embodiment, the ligature 100 is made out of a suture material suitable for suturing a tissue of a patient. The ligature 100 can be made out of existing suture materials such as polymers like PTFE, Polyethylene or similar polymers, and resorbable polymers. The ligature 100 can also be made out of an allograph material such as treated porcine, bovine or human tissue.
  • [0047]
    In one embodiment, a delivery device, described below, is used to deploy the ligature 100 to a heart to treat a faulty heart valve. Such a delivery device is able to attach the two anchoring members 102A and 102B of the ligature 100 to two different attachment sites (e.g., cardiac tissues or tissue areas within or proximate the heart). The anchoring member 102A is attached to one attachment site and the anchoring member 102B is attached to the other attachment site. During the attachment step, the ligature 100 may be stretched so as to reach both attachment sites. In some cases, the ligature 100 does not need to be stretchable for the anchoring members 102A and 102B of the ligature 100 to anchor into the two different attachment sites. After the attachment step, the ligature 100 is able to constrict or reduce the size of the heart valve. In the embodiment where the ligature 100 is flexible, the ligature 100 is stretched during the attachment step and is returned to its unstretched length after the attachment step thus, constricting (or reducing) the size of the heart valve. In the embodiment where the ligature 100 is rigid, the length of the ligature 100 is smaller than the size or the diameter of the heart valve thus, after the attachment step, the valve can be constricted or reduced.
  • [0048]
    In one embodiment, multiple ligatures 100 are placed across the faulty heart valve annulus to reshape or reduce the circumference or perimeter of the heart valve annulus. The ligature 100 may have cross section size that is sufficiently small to not significantly impede the flow of blood (or other fluid) through the heart valve or produce thrombus. The ligature 100 may be of a dimension that is similar to surgical sutures known in the field. The ligature 100 may have a cross section size between 0.001 mm and 5.0 mm. The ligature 100 may have a length between 10 mm and 600 mm. The ligature 100 may have an unstretched length between 10 mm and 600 mm that can be stretched to an appropriate length for deployment purposes and that can be returned to the unstretched length after the deployment of the ligature 100.
  • [0049]
    In some cases, the ligatures 100 are placed across a faulty heart valve and left in place for a specific period of time to improve the heart valve function. In other cases, the ligatures 100 aid in positive remodeling of the left ventricle by constricting (or reducing) the size of the faulty heart valve annulus so as to relieve the left ventricle from working extra hard to pump blood out of the left ventricle to other areas of the body. After this remodeling/recovery time a removal system could be employed at a later date to excise the ligatures 100.
  • [0050]
    In one embodiment, the ligature 100 has two ends wherein the first anchoring member 102A is attached to one end of the ligature 100 and the second anchoring member 102B is attached to the other end of the ligature 100. The anchoring members 102A and 102B are elements that can enter a tissue of a patient body (e.g., a cardiac tissue) and be anchored and retained therein. FIG. 2A illustrates an exemplary configuration of the anchoring members 102A and 102B, which are referred to as “barbed end” configurations. The anchoring members 102A and 102B have pointy ends 106A and 106B. The anchoring members 102A and 102B may also have a plurality of prongs 108A and 108B. The pointy ends 106A and 106B allow the anchoring members 102A and 102B to easily pierce through a tissue wall to begin the anchoring process. The prongs 108A and 108B prevent the anchoring members 102A and 102B from being detached or released from the tissue thus anchoring the anchoring members 102A and 102B to the tissue wall. Each of the anchoring members 102A and 102B has a predetermined length 126A and length 126B, which is dependent upon on the tissue depth that the each of the anchoring members 102A and 102B needs to pierce through to be anchored to the tissue.
  • [0051]
    The anchoring members of the ligature 100 need not have the configurations shown in FIG. 2A. Another possible configurations includes a hook-end configuration as shown in FIG. 2B. The ligature 100 shown in FIG. 2B includes a first hook-end anchoring member 103A and a second hook-end anchoring member 103B. The first hook-end anchoring member 103A and the second hook-end anchoring member 103B can anchor the ends of the ligature 100 to a cardiac tissue similar to the anchoring members 102A and 102B shown in FIG. 2A.
  • [0052]
    In one embodiment, the anchoring members have a helix end configuration as illustrated in FIG. 3. In this embodiment, the ligature 100 includes helix ends 104A and 104B. The helix ends 104A and 104B have ends 105A and 105B that may be pointy, sharp, or blunt depending on the type of tissue that the helix ends are to be anchored to. The helix ends 104A and 104B may be continuous helixes made of shape memory material that can maintains the helix ends 104A and 104B in their helical configuration. The helix ends 104A and 104B enter the tissue by threading and rotating through the tissue similar to action of a screw. Each of the anchoring members 104A and 104B has a predetermined length 127A and length 127B, which is dependent upon on the tissue depth that the each of the helix ends 104A and 104B needs to pierce through to be anchored to the tissue. In another embodiment, the ligature 100 includes double helix ends (not shown) to increase retentive or anchoring strength.
  • [0053]
    The anchoring members (e.g., the anchoring members 102A, 102B, 103A, 103B, 104A, and 104B) of the ligature 100 can be made out of metals, plastic, or any other hard materials that are biocompatible or implantable and are suitable for use in a patient's body. The anchoring members can also be made out of a semi stiff implantable material. The anchoring members can be made out of stainless steel, titanium, titanium alloy, nickel, nickel titanium alloy, chroma alloy or other suitable metal alloys. The anchoring members can also be made out of polymers, high density polyethylene (HDPE), polyglycolic acid, and polyglycolid hydroxyacetic acid. In one embodiment, the anchoring members or at least portions of the anchoring members are coated with a biocompatible lubricious material that provides for easier delivery and entrance into the tissue.
  • [0054]
    FIG. 4 illustrates an exemplary embodiment where two of the ligatures 100 are placed across a heart valve such as a mitral valve. In FIG. 4, a heart 202 includes a mitral valve 204, a mitral valve annulus 206, a left fibrous ring 220, a right fibrous trigone 200 and a left fibrous trigone 210. The mitral valve 204 may be a faulty mitral valve such as those seen in patients having regurgitation. In one embodiment, the ligatures 100 (each including anchoring members 102A and 102B) are placed across the mitral valve 204 in a semi-parallel pattern. In one embodiment, an anchoring member 102A of a ligature 100 is placed in the left fibrous trigone 210 and an anchoring member 102B is placed in a location on the opposite side of the mitral valve annulus 206 in the left fibrous ring 220. Another anchoring member 102A of another ligature 100 is placed in the right fibrous trigone 200 and the other end of another ligature is placed in a location on the opposite side of the mitral valve annulus 206 in the left fibrous ring 220. If necessary, multiple ligatures 100 may be placed across the mitral valve annulus 206 in a semi-parallel pattern.
  • [0055]
    FIG. 5 illustrates another exemplary embodiment where two of the ligatures 100 are placed across a heart valve such as a mitral valve. The placement of the ligatures 100 in FIG. 5 is similar to the placement shown in FIG. 4 except that the ligatures 100 intersect or cross each other. In FIG. 5, a heart 202 includes a mitral valve 204, a mitral valve annulus 206, a left fibrous ring 220, a right fibrous trigone 200 and a left fibrous trigone 210. In one embodiment, the ligatures 100 (each including anchoring members 102A and 102B) are placed across the mitral valve 204 in an intersecting or cross pattern. In one embodiment, an anchoring member 102A of a ligature 100 is placed in the left fibrous trigone 210 and an anchoring member 102B is placed in a location on the opposite side of the mitral valve annulus 206 in the left fibrous ring 220. Another anchoring member 102A of another ligature 100 is placed in the right fibrous trigone 200 and the other end of this ligature 100 is placed in a location on the opposite side of the mitral valve annulus 206 in the left fibrous ring 220. If necessary, multiple ligatures 100 may be placed across the mitral valve annulus 206 in the intersecting or cross pattern.
  • [0056]
    It is to be appreciated that the semi parallel and the intersecting patterns can be combined together for the placements of the ligatures 100 if necessary. Additionally, the anchoring members of the ligatures shown in FIGS. 4 and 5 can have barbed end configurations as those shown for the anchoring members 102A or 102A, helix ends 104A or 104B, as those shown in FIG. 3 or hook ends 103A and 103B as those shown in FIG. 2B, or other types of ends that will anchor the ends of the ligature 100 to a tissue or a cardiac tissue. Also, a ligature 100 may include more than one anchoring member at each end of the ligature 100.
  • [0057]
    FIG. 6 illustrates a perspective view of one exemplary embodiment of a medical device 301 that includes a ligature 100 which can be used to percutaneously deploy a ligature 100 to a heart to treat a faulty heart valve. FIG. 7 illustrates a cross section “A” of the distal end 324 of the medical device 301. FIG. 8 illustrates a cross section “B” of the mid-section of the medical device 301.
  • [0058]
    In one embodiment, the medical device 301 comprises a delivery shaft 300 having a delivery lumen 305 (FIGS. 7-8), a proximal end 322, and a distal end 324. In one embodiment, the delivery shaft 300 is a catheter, which is sized and shaped as generally known in the art to travel within and along the vascular tree to the heart of a patient. A first deployment shaft 310A and a second deployment shaft 310B are disposed within the delivery lumen 305 and extend from the distal end 324 to the proximal end 322. A ligature 100 is releasably coupled to the delivery shaft 300 at the distal end 324 such that the ligature 100 is coupled to the delivery shaft 300 for deployment, and after deployment, the ligature 100 is released from the delivery shaft 300. The ligature 100 includes a first anchoring member 102A and a second anchoring member 102B and the ligature 100 links them as previously described. The medical device 301 can deploy the ligature 100 into a patient wherein the first deployment shaft 310A deploys the first anchoring member 102A to a first tissue area of the patient (e.g., a cardiac tissue, a tissue proximate a mitral valve, or a portion of the mitral valve) and the second deployment shaft 310B deploys the second anchoring member 102B to a second tissue area of the patient (e.g., another cardiac tissue, another tissue proximate a mitral valve, or another portion of the mitral valve).
  • [0059]
    In one embodiment, the ligature 100 is contained in the distal end 324 of the delivery shaft 300 near the cross section “A.” The delivery lumen 305 may be a dumbbell shaped lumen 305. The dumb bell shaped lumen 305 provides a compartment in the distal end of the delivery shaft 300 where the ligature 100 can reside undisturbed as the medical device 301 is advanced to an area of the heart to be treated.
  • [0060]
    In one embodiment, the ligature 100 is housed inside the delivery lumen 305 on the distal end 324. The anchoring member 102A of the ligature 100 is mounted on the distal end of the deployment shaft 310A; and, the anchoring member 102B is mounted on the distal end of the deployment shaft 310B. In one embodiment, the deployment shaft 310A is housed in its own deployment lumen 306 and the deployment shaft 3101B is housed in its own deployment lumen 308. The deployment lumens 306 and 308 may combine together to form the dumb bell shape lumen 305 or may be two separate lumens comprised within the delivery shaft 300. The delivery lumen 305 does not need to (but may) maintain its dumb bell shape for the entire length of the delivery shaft 300 or may only have the dumb bell shape at the distal end 324 of the delivery shaft 300. The delivery shaft 300 may include additional lumens such as additional lumens for the delivery of additional ligatures or for sensing endoscopy or to allow a pull wire to be used to deflect the distal end 324 (in order to control the positions where the anchoring members are anchored).
  • [0061]
    In one embodiment, the delivery shaft 300 is further coupled to a handle member 340, which is used in deploying the ligature or ligatures 100 as shown in FIG. 6. The handle member 340 includes a deployment mechanism 350A and a deployment mechanism 350B, which can advance or retract the deployment shafts 310A and 3101B, respectively, to deploy the ligature 100. In one embodiment, the proximal end of the deployment shaft 310A is connected to the deployment mechanism 350A. The proximal end of the deployment shaft 3101B is connected to the deployment mechanism 350B.
  • [0062]
    In one embodiment, the delivery shaft 300 also includes a guide wire lumen 320 as shown in FIGS. 7-8. The guide wire lumen 320 extends from the distal end 324 of the delivery shaft 300 to the proximal end 322 of the delivery shaft 300, through the handle member 340, and is connected to a guide wire port 360 in the proximal end of the handle member 340. The guide wire lumen 320 is sufficiently sized and shaped to allow for the insertion of a guide wire (not shown). The guide wire may be disposed through the guide wire lumen 320 to guide or maneuver the delivery shaft 300 from the entrance of the patient's body through the body of the patient to reach the area of the heart where the ligature 100 will be deployed, e.g., a mitral valve. In one embodiment, the guide wire port 360 is used to control the advancement, movement, or steering of the guide wire through the patient's body.
  • [0063]
    In one embodiment, the delivery shaft 300 may include reinforcement member such as a plurality of strands disposed in braided pattern, a plurality of fibers kitted together, or a coiled wire (not shown). In another embodiment, the delivery shaft 300 may comprise other lumens or supporting member (not shown) that can be used to steer or aim the distal end 324 of the medical device 301 in a desired direction. These supporting members may be of a pre-shaped nature curving the delivery shaft 300 as the supporting members are advanced within a lumen to the distal end 324 of the delivery shaft 300. One or more of these steering lumen and supporting member may be present in the delivery shaft 300.
  • [0064]
    In another embodiment, a supporting member may consist of a member (not shown) that is coupled to the distal end 324 of a steering lumen included within the delivery shaft 300. The steering lumen can be the guidewire lumen 320 shown in FIGS. 7-8. The supporting member may extend from the distal end 324 to the proximal end 322 of the delivery shaft 300. In one embodiment, pulling on this supporting member at the proximal end 322 causes the distal end 324 of the delivery shaft to become curved. In another embodiment, the steering lumen is pressurized causing the distal end 324 of the delivery system to bend in a desired direction.
  • [0065]
    In one embodiment, the guide wire lumen 320 may only be present in the distal end 322 of the delivery shaft 300 as in common rapid exchange catheter design known in the art. A common rapid exchange catheter is well known in the art. In another embodiment, the guide wire lumen 320 may absent from the delivery shaft 300 and may be replaced by one or more tendons to produce a bendable tip delivery shaft 300.
  • [0066]
    The delivery shaft 300 may be made out of numerous different types of materials. In one embodiment, the delivery shaft 300 is made out of materials that are suitable for inserting into a patient's body. For example, the delivery shaft 300 may be made out of materials suitable for making a catheter. The delivery shaft 300 may be made out of polyether block amid (PEBA), polyethylene (PE), polyproplylene (PP), polyvinylchloride (PVC), polytetrafluoroethylene (PTFE), or polyurethane, or other types of biocompatible material.
  • [0067]
    In one embodiment, the delivery shaft 300 comprises at least one radiopaque marker to aid the operator (e.g., a physician) in the monitoring, placing, or inserting of the delivery shaft 300 into a patient. The radiopaque marker can be a band of radiopaque material disposed proximate the distal end 324 of the delivery shaft 300. The radiopaque material aids the operator in determining the location of the distal end 324 of the delivery shaft 300. Examples of a radiopaque material include gold, platinum, tungsten, iron, silver, and thermoplastic material loaded with a radiopaque filler such as barium sulfate, bismuth subcarbonate, bismuth trioxide, bismuth oxychloride, tungsten power, and depleted uranium, etc. In another embodiment, the delivery shaft 300 comprises at least one Magnetic Resonance Imaging (MRI) marker to aid the operator in the monitoring, placing, or inserting of the delivery shaft 300 into a patient. An example of an MRI marker materials include platinum, tungsten, iridium, barium sulfate, plastic, or other particles suitable for a MRI process. Alternatively, the MRI marker can be an active component such as a small circuit that can generate a radio frequency (RF) that an MRI scanner can detect.
  • [0068]
    FIG. 9 illustrates a perspective view of the medical device 301 wherein the delivery shaft 300 is deploying the ligature 100 that is releasably coupled to the delivery shaft 300. In one embodiment, the medical device 301 is used to deploy the ligature 100 to place the ligature 100 across the mitral valve as illustrated in FIG. 4-5. The medical device 301 can be used to deploy the ligature 100 to other area of the heart, for example, within a coronary sinus (see FIG. 15A) or over the left ventricle of the heart (see FIGS. 14B and 14C).
  • [0069]
    In one embodiment, advancing the deployment shaft 310A advances the anchoring member 102A of the ligature 100 out of the delivery shaft 300 as illustrated in FIG. 9. As the deployment shaft 310A is advanced, the anchoring member 102A is advanced from the lumen 305 at the distal end 324 of the delivery shaft 300 to a tissue area 326. Once the anchoring member 102A is anchored to the tissue area 326, the deployment shaft 310A can be retracted into the delivery shaft 300 leaving the anchoring member 102A embedded in the tissue area 326. In one embodiment, the deployment shaft 310A is retracted as illustrated in FIG. 10 wherein the anchoring member 102A is left attached or anchored to the tissue area 326. This process can be repeated for the anchoring member 102B of the ligature 100. The deployment shaft 310B is advanced out of the delivery shaft 300 thus advancing the anchoring member 102B. In one embodiment, the anchoring member 102B is anchored to a tissue area 328 which can be substantially opposite the tissue area 326 where the anchoring member 102A is anchored. Once the anchoring member 102B is anchored into the tissue area 328, the deployment shaft 310B is retracted into the delivery shaft 300.
  • [0070]
    In the embodiment where the ligature 100 is flexible, once both of the anchoring members 102A and 102B of the ligature 100 are anchored, the ligature 100 is allowed to return to its original length (unstretched length) or its original shape, thus, bringing the tissue areas 326 and 328 closer to each other. When the tissue areas 326 and 328 are brought closer to each other, the heart structure that the ligature 100 is placed across, e.g., the mitral valve, is narrowed, reduced, or constricted. In the embodiment where the ligature 100 is made of a rigid material, once the anchoring members 102A and 102B of the ligature 100 are anchored, the ligature 100 pull the tissue areas 326 and 328 are closer to each other. Again, when the tissue areas 326 and 328 are brought closer to each other, the heart structure that the ligature 100 is placed across, e.g., the mitral valve, is narrowed, reduced, or constricted.
  • [0071]
    The medical devices 301 shown in FIGS. 6-8 and 9-10 include the ligature 100 that has barbed end configurations for the anchoring members 102A and 102B. It is to be appreciated that the anchoring members 102A and 102B may have other configurations, for examples, helixes, or hooks as shown in FIGS. 2B and 3.
  • [0072]
    FIGS. 11A-11B illustrate an exemplary medical device 302. The medical device 302 is similar to the medical device 301 except that the device 302 is more preferred for delivering a ligature 100 that has helix ends as the anchoring members. As illustrated in FIGS. 11A-11B, the medical device 302 comprises a delivery shaft 303 having a delivery lumen 318, a proximal end 332, and a distal end 334. In one embodiment, the delivery shaft 303 is a catheter, which is sized and shaped as generally known in the art to travel within and along the vascular tree to the heart of a patient. In another embodiment, the delivery shaft 303 is the same as the delivery shaft 300.
  • [0073]
    In one embodiment, a first deployment shaft 307 and a second deployment shaft 309 are disposed within the delivery lumen 318 and extended from the distal end 334 to the proximal end 332. A ligature 100 is releasably coupled to the delivery shaft 303 at the distal end 334 such that the ligature 100 is coupled to the delivery shaft 303 for deployment, and after deployment, the ligature 100 is released from the delivery shaft 303. The ligature 100 includes a first anchoring member 104A and a second anchoring member 104B which are of helix ends. The medical device 302 can deploy the ligature 100 into a patient wherein the first deployment shaft 307 deploys the first anchoring member 104A to a first tissue area of the patient (e.g., a cardiac tissue, a tissue proximate a mitral valve, or a portion of the mitral valve) and the second deployment shaft 309 deploys the second anchoring member 104B to a second tissue area of the patient (e.g., a cardiac tissue, a tissue proximate a mitral valve, or a portion of the mitral valve).
  • [0074]
    In one embodiment, the ligature 100 is contained in the distal end 334 of the delivery shaft 303. The delivery lumen 318 may be a dumbbell shaped lumen 318. The dumb bell shaped lumen 318 provides a compartment in the distal end of the delivery shaft 303 where the ligature 100 can reside undisturbed as the medical device 302 is advanced through the patient's vasculature to an area of the heart to be treated.
  • [0075]
    In one embodiment, the ligature 100 is housed inside the delivery lumen 318 on the distal end 334. The anchoring member 104A of the ligature 100 is mounted on the distal end of the deployment shaft 307; and, the anchoring member 104B is mounted on the distal end of the deployment shaft 309. In one embodiment, the deployment shaft 307 is housed in its own deployment tube 336 and the deployment shaft 308 is housed in its own deployment tube 338 as illustrated in FIG. 1I B. The deployment tubes 336 and 338 may combine together to form the dumb bell shape lumen 318 or may be two separate tubes disposed within the delivery shaft 303. The delivery lumen 318 does not need (but may) maintain its dumb bell shape for the entire length of the delivery shaft 303 or may only have the dumb bell shape at the distal end 334 of the delivery shaft 303.
  • [0076]
    In one embodiment, the delivery shaft 303 is further coupled to a handle member 304, which is used to deploy the ligature or ligatures 100. The handle member 304 includes a deployment mechanism 350A and a deployment mechanism 350B, which can advance or retract the deployment shafts 307 and 309, respectively, to bring the ligature 100 closer to the anchoring sites. In one embodiment, at least a section near the proximal end of the deployment shaft 307 is connected to the deployment mechanism 350A. A section near the proximal end of the deployment shaft 309 is connected to the deployment mechanism 350B. In one embodiment, as the deployment shafts 309 and 309 are advanced or retraced, the anchoring members 104A and 104B of the ligature 100 are advanced or retracted.
  • [0077]
    The handle member 304 also includes a rotating mechanism 314 and a rotating mechanism 316, which can rotate the deployment shafts 307 and 309 as the deployment shafts 307 and 309 are advanced or retracted. In one embodiment, the proximal end of the deployment shaft 307 is connected to the rotating mechanism 314. The proximal end of the deployment shaft 309 is connected to the rotating mechanism 316. In one embodiment, rotating the rotating mechanism 314 rotates the deployment shaft 307 thus rotating the anchoring member 104A. Similarly, rotating the rotating mechanism 316 rotates the deployment shaft 309 thus rotating the anchoring member 104B.
  • [0078]
    In one embodiment, the deployment tubes 336 and 338 are connected to the deployment mechanisms 350A and 350B, respectively. In this embodiment, the deployment tubes 336 and 338 are advanced or retracted by the deployment mechanisms 350A and 350B. As the deployment tube 336 and 338 are advanced or retracted, the deployment shafts 307 and 309 are also advanced or retracted. Thus, in this case, to deploy the anchoring members 104A and 104B, the deployment mechanisms 350A and 350B advance the deployment tubes 336 and 338, respectively. The deployment tubes 336 and 338 may be advanced completely out of the delivery shaft 303 or may only be partially advanced. Then, the deployment shafts 307 and 309 are then rotated by the rotating mechanisms 314 and 316, respectively to deploy the anchoring members 104A and 104B.
  • [0079]
    In one embodiment, the delivery shaft 303 also includes a guide wire lumen 312 as illustrated in FIGS. 11A-11B. The guide wire lumen 312 extends from the distal end 334 of the delivery shaft 303 to the proximal end 332 of the delivery shaft 303, and through the handle member 304 and is connected to a guide wire port 330 located at the proximal end of the handle member 304. The guide wire lumen is sufficiently sized and shaped to allow for the insertion of a guide wire (not shown). The guide wire may be disposed through the guide wire lumen 312 to guide or maneuver the delivery shaft 303 through the body of the patient to reach the area of the heart where the ligature 100 is to be deployed, e.g., a mitral valve. In one embodiment, the guide wire port is used to control the advancement, movement, or steering of the guide wire through the patient's body.
  • [0080]
    In one embodiment, the delivery shaft 303 may include reinforcement member similar to the delivery shaft 300 described above. In another embodiment, the delivery shaft 303 may comprise other lumens or supporting member that can be used to steer or aim the distal end 334 of the medical device 302 in a desired direction. These supporting members may be of a pre-shape nature curving the delivery shaft 303 as the supporting members are advanced within a lumen to the distal end 334 of the delivery shaft 303. One or more of these steering lumen and supporting member may be present in the delivery shaft 303.
  • [0081]
    In another embodiment, a supporting member may consist of a member (not shown) that is coupled to the distal end 334 of a steering lumen included within the delivery shaft 303. The steering lumen can be the guidewire lumen 312 shown in FIGS. 11A-11B. The supporting member may extend from the distal end 334 to the proximal end 332 of the delivery shaft 303. In one embodiment, pulling on this supporting member at the proximal end 332 causes the distal end 334 of the delivery shaft to become curved. In another embodiment, the steering lumen is pressurized causing the distal end of the delivery system to bend in a desired direction.
  • [0082]
    In one embodiment, the guide wire lumen 312 may only be present in the distal end 332 of the delivery shaft 303 as in common rapid exchange catheter design as is known in the art. In another embodiment, the guide wire lumen 312 may absent from the delivery shaft 303 and may be replaced by one or more tendons to produce a bendable tip delivery shaft 303.
  • [0083]
    The delivery shaft 303 may made out of numerous different types of materials similar to the material used to make the delivery shaft 300 described above. Also, similar to the delivery shaft 300, the delivery shaft 303 may also comprise at least one radiopaque marker or an MRI marker to aid the operator (e.g., a physician) in the monitoring, placing, or inserting of the delivery shaft 303 into a patient.
  • [0084]
    FIGS. 12A-12G illustrate an exemplary deployment shaft that can be used with the medical device 302 to deploy the ligature 100. The deployment shaft can be the deployment shaft 307 or 309 shown in FIGS. 11A-11B. In one embodiment, the deployment shaft 307 shown in FIG. 12A is disposed within the deployment tube 336 as shown in FIG. 12B. In one embodiment, the deployment shaft 307 includes a slot 342 wherein a portion of the ligature 100 can reside until deployment. The slot 342 is useful in that it helps keep the ligature 100 from being entangled between two deployment shafts 307 and 309. The slot 342 is not necessary for the deployment shaft 307 or 309 to function properly in deploying the ligature 100.
  • [0085]
    In one embodiment, a portion of the ligature 100 proximate the anchoring member 104A is spiraled around the deployment shaft 307 (as shown in FIG. 12D); and, the other portion of the ligature 100 proximate the anchoring member 104B would be spiraled around the deployment shaft 309 in a similar manner (not shown). In the embodiment where the deployment shafts 307 and 309 each includes a slot 342, the portion of the ligature 100 that is not wound around the deployment shafts 307 and 309 extends through the slot 342. The ligature 100 extending from one slot 342 of one deployment shaft (e.g., deployment shaft 307) can be inserted into another slot 342 on another deployment shaft (e.g., deployment shaft 309).
  • [0086]
    In one embodiment, the distal end of the deployment shaft 307 further comprises an axis 344 such that the helix anchoring member 104A can be kept there or releasably coupled thereto until the deployment of the ligature 100. The deployment shaft 307 with the ligature 100 releasably coupled thereto can be disposed within the deployment tube 336 as illustrated in FIG. 12E. FIGS. 12F-G further illustrates the distal end 334 of the delivery shaft 302 wherein the deployment shafts 307 and 309 are disposed within the deployment tube 336 and 338, respectively.
  • [0087]
    It is to be appreciated that a similar construction to the deployment shaft 307 can used for the ligature 100 with the barbed end configurations for the anchoring member 102A and 102B described above. In this embodiment, the barbed end will be kept at the axis 344 until after deployment.
  • [0088]
    FIGS. 13A-13H illustrate an exemplary process of deploying the ligature 100 that includes helix ends anchoring members. At FIGS. 13A-13B, the deployment tube 336 is advanced in order to advance the deployment shaft 307 (not visible in these figures) toward a tissue area 344. Advancing the deployment shaft 307 would advance the helix ends 104A toward the tissue area 344. In one embodiment, the deployment tube 336 is advanced toward the tissue area 344 by a deployment mechanism, such as the deployment mechanism 350A shown in FIG. 11. After the advancement, the deployment shaft 307 is then rotated by a rotating mechanism such as the rotating mechanism 314 shown in FIG. 11. In this case, the linkage portion of the ligature 100 which joins the two anchoring members, the helix ends 104A and 104B, is flexible and twistable so that one helix end can be rotated while the other helix end is not. As the deployment shaft 307 is rotated, the helix end 104A is also rotated allowing it to pierce through the tissue area 344 as illustrated in FIG. 13C. In one embodiment, upon advancing, the helix end 104A is rotated in a direction that would enhance the advancement of the helix end 104A into the tissue area 344. The rotation of the deployment shaft 307 is initiated by a rotation of the rotating mechanism. Once the helix end 104A is anchored to the tissue area 344, the deployment tube 336 together with the shaft 307 is retracted into the delivery shaft 303 leaving the helix end 104A embedded (or anchored) in the tissue area 344 as illustrated in FIG. 13D. This process can be repeated for the helix end 104B of the ligature 100.
  • [0089]
    As shown in FIGS. 13D-13E, the deployment tube 338 is advanced out of the delivery shaft 303 to advance the deployment shaft 309 to a tissue area 346. Advancing the deployment shaft 309 would advance the helix end 104B toward the tissue area 346. After the advancement, the deployment shaft 309 is rotated by a rotating mechanism such as the rotating mechanism 316 shown in FIG. 11. As the deployment shaft 309 is rotated, the helix end 104B is also rotated allowing it to pierce through the tissue area 346 as illustrated in FIGS. 13E-F. In one embodiment, upon advancing, the helix end 104B is rotated in a direction that would enhance the advancement of the helix end 104B into the tissue area 346. Once the helix end 104B is anchored to the tissue area 346 as shown in FIG. 13F, the deployment shaft 309 is retracted into the delivery shaft 303 leaving the helix end 104B embedded in the tissue area 346 as illustrated in FIGS. 3G-H.
  • [0090]
    After the helix ends 104A and 104B are anchored to the tissue area 344 and 346, respectively, the delivery shaft 303 may then be retracted from the tissue area 344 and 346. The process described in FIGS. 13A-13H may be repeated as needed to deploy as many ligatures 100 as necessary. In one embodiment, the process is used to constrict a heart valve such as a mitral valve by placing multiple ligatures 100 across the mitral valve's annulus. In one embodiment, the tissue area 344 and 346 are the fibrous tissue around the annulus of the mitral valve. The anchoring of the helix ends 104A and 104B thus places the ligature 100 across the heart valve to reduce or constrict the size of the heart valve. The ligatures 100 with the helix ends can be placed across the mitral valve using this process to place the ligatures 100 similarly to what is depicted in FIGS. 4 and 5.
  • [0091]
    FIG. 14A illustrates an exemplary route of percutaneously inserting the ligatures 100 into a patient's heart 110. As previously mentioned, by percutaneous deployment, the ligature 100 is deployed through blood vessels, veins, or arteries into a patient. In one embodiment, the ligature 100 is deployed through the blood vessels, veins, or arteries and into the heart area of a patient.
  • [0092]
    In one embodiment, FIG. 14A illustrates an exemplary route of percutaneously inserting the ligatures 100 into the heart 110 and placing the ligatures 100 across the mitral valve 120 of the heart 110. In one embodiment, a medical device containing the ligature 100 is introduced into the patient's body percutaneously using a modified Seldinger technique in which the medical device is inserted into the venous vascular tree through the femoral vein. In one embodiment, the medical device enters or reaches the annulus of the mitral valve 120 from the atrial side of the heart 110. A medical device 130 is first provided. The medical device 130 can be the medial device 301 or the medical device 302 described above. The medical device 130 can also be a catheter capable of delivering and deploying a ligature 100 to the heart. The medical device 130 is advanced up the inferior vena cava (IVC) 122 and into the right atrium (RA) 112 of the heart 110. The medical device 130 then enters then left atrium (LA) 114 of the heart 110. In one embodiment, the medical device 130 crosses the atrial septum 124 through a small atrial septostomy (created by cardiological techniques known in the art) to enter the left atrium 114 of the heart 110. In one embodiment, a guidewire (not shown) is placed across the atrial septostomy and the medical device 130 is threaded along the guidewire and into the left atrium 114. The medical device 130 is stopped at a predetermined point in, at, or in proximity to the mitral valve 120. In one embodiment, the medical device 130 may have a preformed or deflectable short hook configuration at its tip region to facilitate the insertion of the medical device 130 into the mitral valve area. Once the medical device 130 reaches the area in, at, or in proximity to mitral valve 120, the ligature 100 can be deployed as previous described and be placed across the mitral valve in similar manners as those shown in FIGS. 4-5.
  • [0093]
    FIG. 14B illustrates an exemplary route of percutaneously inserting the ligatures 100 into a patient's heart 110 to perform a ventricular remodeling of the heart. In ventricular remodeling, the ligature (or ligatures) 100 can be used to reduce the size of the ventricle by placing these ligatures around the left ventricle (which is typically the ventricle that is enlarged due to a faulty mechanism in the heart such as regurgitation). With the ligatures 100 placed around the left ventricle, the size of the left ventricle can be reduced, hence, remodeled.
  • [0094]
    Continuing with FIG. 14B, in one embodiment, a medical device 130 is first provided. In one embodiment, the medical device 130 can be the medial device 301 or the medical device 302 described above. In another embodiment, the medical device 130 can be a catheter capable of delivering and deploying a ligature 100 to the heart. The medical device 130 is advanced up the inferior vena cava (IVC) 122 and into the right atrium (RA) 112 of the heart 110. The medical device 130 then enters then left atrium (LA) 114 of the heart 110. In one embodiment, the medical device 130 crosses the atrial septum 124 through a small atrial septostomy (created by cardiological techniques known in the art) to enter the left atrium 114 of the heart 110. In one embodiment, a guidewire (not shown) is placed across the atrial septostomy and the medical device 130 is threaded along the guidewire and into the left atrium 114. The medical device 130 is advanced through the mitral valve 120 to enter the left ventricle 118. In one embodiment, the medical device 130 may have a preformed or deflectable short hook configuration at its tip region to facilitate the insertion of the medical device 130 into the mitral valve area. Once the medical device 130 is inserted through the mitral valve 120, the ligature 100 can be deployed as previous described to anchor one of the anchoring members into the papillary muscles in the left ventricle 118 and the other anchoring member into a cardiac tissue opposite the heart muscles. This process is repeated to deploy several ligatures 100 as it may be necessary to employ more than one ligature to reduce the size of an enlarged left ventricle. In one embodiment, after several ligatures 100 have been deployed, the ligatures surround the left ventricle 118 as shown in FIG. 14B.
  • [0095]
    FIG. 14C illustrates another exemplary route of percutaneously inserting the ligatures 100 into a patient's heart 110 to perform a ventricular remodeling of the heart. A medical device 130 is first provided. In one embodiment, the medical device 130 can be the medial device 301 or the medical device 302 described above. In another embodiment, the medical device 130 can be a catheter capable of delivering and deploying a ligature 100 to the heart. The medical device 130 is advanced up the aorta 119 and directly into the left ventricle 118. In one embodiment, the medical device 130 may have a preformed or deflectable short hook configuration at its tip region to facilitate the insertion of the medical device 130 into the left ventricle 118. Once the medical device 130 reaches the left ventricle 118, the ligature 100 is deployed as previous described to place the ligature 100 into the tissues of the left ventricle 118. One such tissue is the heart muscles in the left ventricle 118. This process is repeated to deploy several ligatures 100 as it may be necessary to employ more than one ligature to reduce the size of an enlarged left ventricle. In one embodiment, after several ligatures 100 have been deployed, the ligatures span the interior of the left ventricle 118 as shown in FIG. 14C.
  • [0096]
    FIG. 15A illustrates an alternative embodiment of placing the ligature 100 around a mitral valve. In this embodiment, the ligature 100 described previously is placed within the coronary sinus 212 of the heart 202. The coronary sinus 212 substantially encircles the mitral valve annulus 206 of the mitral valve 204. A first anchoring member of the ligature 100 (e.g., the first anchoring member 102A) extends outside one end of the coronary sinus 218 and anchors into the left fibrous trigone 210. A second anchoring member of the ligature 100 (e.g., the second anchoring member 102B) extends outside the coronary sinus 218 and anchors into the right fibrous trigone 200. In one embodiment, the ligature 100 has a preformed shape such that once the ligature 100 is deployed and that the first and the second anchoring members are anchored, the ligature 100 bends and reduces the radius of curvature of the coronary sinus 218. In this embodiment, the ligature 100 can be made of a shape memory material and may be flexible or rigid. The ligature 100 may be made of a shape memory material such as Nitinol or other material that has a memory of an original shape as shown in FIG. 15B and can be temporarily stretched or forced into another shape during deployment as shown in FIG. 15C and FIG. 15D. Since the coronary sinus 218 substantially encircles the mitral valve annulus 206, the reduction of the radius of curvature of the bent coronary sinus 218 will result in a diameter and circumference reduction of the mitral valve annulus 206. In one embodiment the ligature 100 is surrounded or encapsulated by a jacket so as to prevent the ligature 100, once deployed within the coronary sinus 218, from cutting through the coronary sinus 218.
  • [0097]
    FIG. 16 illustrates an exemplary method 150 of treating a faulty heart valve by constricting or reducing the size of the heart valve. At operation 152, a medical device such as the medical device 301 or 302 described above is provided. At operation 154, the ligature 100 is deployed into the patient wherein the first deployment shaft (e.g., the deployment shaft 310A, or 307) deploys the first anchoring member (e.g., the anchoring member 102A or 104A) to a first tissue area around the heart valve and the second deployment shaft (e.g., the deployment shaft 3101B, or 309) deploys the second anchoring member (e.g., the anchoring member 102B or 104B) to a second tissue area of the heart valve. The ligature 100 can be deployed using the embodiments previously described. Deploying the ligature 100 anchors the first anchoring member to the first tissue area and the second anchoring member to the second tissue area as described above. The method 150 can be repeated in embodiments where multiple ligatures 100 are to be placed across the heart valve. The number of ligatures 100 sufficient to treat a faulty heart valve depends on how much of the size of the faulty heart valve needs to be constricted or reduced. The cross section size of each of the ligatures 100 is sufficiently small so as to not cause thrombus or to not significantly impede the blood flow through the heart valve. The length of each of the ligatures 100 can be varied depending on the area the ligature 100 needs to constrict or reduce.
  • [0098]
    The percutaneous methods described above can be used to place the ligature(s) 100 across the mitral valve to constrict (or reduce) the size of a faulty or defective heart valve. In one embodiment, the ligatures 100 are placed across the mitral valve in order to prevent back flow of blood that a patient with a regurgitation condition caused by a faulty mitral valve would experience. The described medical devices including the ligatures 100 that enable percutaneous introduction of the ligatures 100 into patients can replace those cases that require surgical procedures to reduce or constrict the mitral valve. Such a percutaneous method also reduces patient discomfort, improves recovery time, and reduces hospitalization time relatives to a surgical procedure in which the chest is opened.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3177543 *Nov 14, 1962Apr 13, 1965Fountain Cecil DSafety locking device
US3716058 *Jul 17, 1970Feb 13, 1973Atlanta Res InstBarbed suture
US4719924 *Sep 9, 1986Jan 19, 1988C. R. Bard, Inc.Small diameter steerable guidewire with adjustable tip
US4817250 *Jan 21, 1988Apr 4, 1989Nifco, Inc.Cord lock
US4830023 *Nov 27, 1987May 16, 1989Medi-Tech, IncorporatedMedical guidewire
US4920980 *Sep 14, 1987May 1, 1990Cordis CorporationCatheter with controllable tip
US4927421 *May 15, 1989May 22, 1990Marlowe Goble EProcess of endosteal fixation of a ligament
US4994067 *Feb 17, 1989Feb 19, 1991American Biomed, Inc.Distal atherectomy catheter
US5100418 *Dec 15, 1989Mar 31, 1992Inbae YoonSuture tie device system and applicator therefor
US5100421 *Feb 5, 1991Mar 31, 1992Cyprus Endosurgical Tools, Inc.Christoudias curved needle suture assembly
US5102421 *Jun 14, 1990Apr 7, 1992Wm. E. Anpach, IIISuture anchor and method of forming
US5116337 *Jun 27, 1991May 26, 1992Johnson Lanny LFixation screw and method for ligament reconstruction
US5201598 *Jul 31, 1991Apr 13, 1993Tehan Frank VAttachment of cord to tube end using locking sleeve to permit easy cord replacement
US5383260 *Dec 11, 1992Jan 24, 1995Avery Dennison CorporationFastener clip including one or more fasteners adapted for attaching buttons to a garment or like material
US5487757 *Feb 21, 1995Jan 30, 1996Medtronic CardiorhythmMulticurve deflectable catheter
US5495974 *May 2, 1994Mar 5, 1996Avery Dennison CorporationFastener attaching tool
US5518162 *Jan 24, 1994May 21, 1996Avery Dennison CorporationFastener attaching tool
US5520700 *Nov 10, 1993May 28, 1996Technion Research & Development Foundation, Ltd.Stapler device particularly useful in medical suturing
US5609598 *Dec 30, 1994Mar 11, 1997Vnus Medical Technologies, Inc.Method and apparatus for minimally invasive treatment of chronic venous insufficiency
US5613937 *Aug 23, 1994Mar 25, 1997Heartport, Inc.Method of retracting heart tissue in closed-chest heart surgery using endo-scopic retraction
US5617854 *Jun 22, 1994Apr 8, 1997Munsif; AnandShaped catheter device and method
US5626613 *May 4, 1995May 6, 1997Arthrex, Inc.Corkscrew suture anchor and driver
US5632754 *Dec 23, 1994May 27, 1997Devices For Vascular InterventionUniversal catheter with interchangeable work element
US5709224 *Jun 7, 1995Jan 20, 1998Radiotherapeutics CorporationMethod and device for permanent vessel occlusion
US5728129 *Jun 7, 1995Mar 17, 1998American Biomed, Inc.Distal atherectomy catheter
US5865800 *Oct 8, 1996Feb 2, 1999Boston Scientific CorporationDeflectable catheter
US5868733 *Apr 14, 1995Feb 9, 1999Daig CorporationGuiding introducer system for use in the treatment of accessory pathways around the mitral valve using a retrograde approach
US5868767 *Jan 17, 1997Feb 9, 1999Devices For Vascular InterventionUniversal catheter with interchangeable work element
US6017358 *May 1, 1997Jan 25, 2000Inbae YoonSurgical instrument with multiple rotatably mounted offset end effectors
US6021340 *Jul 7, 1998Feb 1, 2000Cardima, Inc.Guiding catheter for the coronary sinus
US6027514 *Dec 17, 1997Feb 22, 2000Fox Hollow Technologies, Inc.Apparatus and method for removing occluding material from body lumens
US6036715 *May 28, 1997Mar 14, 2000Yock; Paul G.Angioplasty apparatus facilitating rapid exchanges
US6045497 *Jul 29, 1998Apr 4, 2000Myocor, Inc.Heart wall tension reduction apparatus and method
US6050936 *Jan 2, 1997Apr 18, 2000Myocor, Inc.Heart wall tension reduction apparatus
US6051008 *Dec 15, 1998Apr 18, 2000Angiotrax, Inc.Apparatus having stabilization members for percutaneously performing surgery and methods of use
US6059715 *Jan 4, 1999May 9, 2000Myocor, Inc.Heart wall tension reduction apparatus
US6174323 *Jun 5, 1998Jan 16, 2001Broncus Technologies, Inc.Method and assembly for lung volume reduction
US6176240 *Jun 7, 1995Jan 23, 2001Conceptus, Inc.Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6178346 *Oct 23, 1998Jan 23, 2001David C. AmundsonInfrared endoscopic imaging in a liquid with suspended particles: method and apparatus
US6179840 *Jul 23, 1999Jan 30, 2001Ethicon, Inc.Graft fixation device and method
US6182664 *Feb 18, 1997Feb 6, 2001Edwards Lifesciences CorporationMinimally invasive cardiac valve surgery procedure
US6183411 *Sep 21, 1998Feb 6, 2001Myocor, Inc.External stress reduction device and method
US6187040 *May 3, 1999Feb 13, 2001John T. M. WrightMitral and tricuspid annuloplasty rings
US6190401 *Jul 2, 1997Feb 20, 2001United States Surgical CorporationDevice for applying a meniscal staple
US6190408 *Mar 5, 1998Feb 20, 2001The University Of CincinnatiDevice and method for restructuring the heart chamber geometry
US6203531 *Aug 5, 1997Mar 20, 2001Daig CorporationGuiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach
US6210407 *Dec 3, 1998Apr 3, 2001Cordis Webster, Inc.Bi-directional electrode catheter
US6210432 *Jun 30, 1999Apr 3, 2001Jan Otto SolemDevice and method for treatment of mitral insufficiency
US6231561 *Sep 20, 1999May 15, 2001Appriva Medical, Inc.Method and apparatus for closing a body lumen
US6231587 *Mar 11, 1999May 15, 2001Transvascular, Inc.Devices for connecting anatomical conduits such as vascular structures
US6355030 *Sep 25, 1998Mar 12, 2002Cardiothoracic Systems, Inc.Instruments and methods employing thermal energy for the repair and replacement of cardiac valves
US6371978 *May 8, 2001Apr 16, 2002Advanced Cardiovascular Systems, Inc.Bifurcated stent delivery system having retractable sheath
US6374476 *Mar 3, 1999Apr 23, 2002Codris Webster, Inc.Method for making a catheter tip section
US6517553 *Jan 24, 2001Feb 11, 2003Abbott LaboratoriesDevice and method for suturing of internal puncture sites
US6537198 *Mar 21, 2000Mar 25, 2003Myocor, Inc.Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US6537314 *Jan 30, 2001Mar 25, 2003Ev3 Santa Rosa, Inc.Percutaneous mitral annuloplasty and cardiac reinforcement
US6551271 *Apr 30, 2001Apr 22, 2003Biosense Webster, Inc.Asymmetrical bidirectional steerable catheter
US6554794 *Jun 4, 1999Apr 29, 2003Richard L. MuellerNon-deforming deflectable multi-lumen catheter
US6554852 *Aug 24, 2000Apr 29, 2003Michael A. OberlanderMulti-anchor suture
US6676702 *May 14, 2001Jan 13, 2004Cardiac Dimensions, Inc.Mitral valve therapy assembly and method
US6706065 *Jul 19, 2001Mar 16, 2004Ev3 Santa Rosa, Inc.Endoluminal ventricular retention
US6709442 *Aug 31, 2001Mar 23, 2004Onux Medical, Inc.Vascular bypass grafting instrument and method
US6709456 *Oct 1, 2001Mar 23, 2004Ev3 Santa Rosa, Inc.Percutaneous mitral annuloplasty with hemodynamic monitoring
US6712804 *Jul 13, 2001Mar 30, 2004Ev3 Sunnyvale, Inc.Method of closing an opening in a wall of the heart
US6718985 *May 25, 2001Apr 13, 2004Edwin J. HlavkaMethod and apparatus for catheter-based annuloplasty using local plications
US6719767 *Sep 26, 2000Apr 13, 2004Edwards Lifesciences CorporationDevice and a method for treatment of atrioventricular regurgitation
US6723038 *Oct 6, 2000Apr 20, 2004Myocor, Inc.Methods and devices for improving mitral valve function
US6733500 *Apr 24, 2002May 11, 2004Medtronic, Inc.Method and system for delivering a medical electrical lead within a venous system
US6852124 *Sep 16, 2002Feb 8, 2005Advanced Cardiovascular Systems, Inc.Variable strength stent
US6890353 *Mar 22, 2002May 10, 2005Viacor, Inc.Method and apparatus for reducing mitral regurgitation
US6989028 *Jan 30, 2002Jan 24, 2006Edwards Lifesciences AgMedical system and method for remodeling an extravascular tissue structure
US6997951 *Dec 24, 2002Feb 14, 2006Edwards Lifesciences AgMethod and device for treatment of mitral insufficiency
US7160318 *Mar 22, 2002Jan 9, 2007Cook IncorporatedModular stent graft assembly and use thereof
US7186264 *Mar 29, 2002Mar 6, 2007Viacor, Inc.Method and apparatus for improving mitral valve function
US7364567 *Jun 10, 2002Apr 29, 2008Abbott Cardiovascular Systems Inc.Systems and methods for detecting tissue contact and needle penetration depth
US20020010483 *Aug 19, 1999Jan 24, 2002Brett FollmerApparatus and methods for removing material from a body lumen
US20020010486 *Jun 8, 2001Jan 24, 2002Ferton Holding S.A.Device for removal of calculi
US20020013571 *Jun 27, 2001Jan 31, 2002Evalve, Inc.Methods and devices for capturing and fixing leaflets in valve repair
US20020016628 *Oct 1, 2001Feb 7, 2002Langberg Jonathan J.Percutaneous mitral annuloplasty with hemodynamic monitoring
US20020026216 *Oct 17, 2001Feb 28, 2002Grimes Randall Y.Devices and methods for percutaneous mitral valve repair
US20020035361 *Jul 3, 2001Mar 21, 2002Houser Russell A.Apparatus and methods for treating tissue
US20020042651 *Jun 29, 2001Apr 11, 2002Liddicoat John R.Method and apparatus for performing a procedure on a cardiac valve
US20030050598 *Sep 13, 2001Mar 13, 2003Hayzelden Robert C.Adjustable profile steerable catheter
US20030069593 *Aug 30, 2002Apr 10, 2003Tremulis William S.Method and apparatus for valve repair
US20030078465 *Oct 11, 2002Apr 24, 2003Suresh PaiSystems for heart treatment
US20030083538 *Nov 1, 2001May 1, 2003Cardiac Dimensions, Inc.Focused compression mitral valve device and method
US20030093071 *Nov 15, 2001May 15, 2003Hauck Wallace N.Cardiac valve leaflet stapler device and methods thereof
US20040010231 *Jul 13, 2001Jan 15, 2004Leonhardt Howard JDeployment system for myocardial cellular material
US20040044350 *May 19, 2003Mar 4, 2004Evalve, Inc.Steerable access sheath and methods of use
US20040044365 *Sep 3, 2002Mar 4, 2004Bachman Alan B.Single catheter mitral valve repair device and method for use
US20040049207 *May 19, 2003Mar 11, 2004Evalve, Inc., A Delaware CorporationFixation device and methods for engaging tissue
US20040059531 *Aug 8, 2003Mar 25, 2004Yasuyuki TomidaRemote control receiving system
US20040098092 *Jul 18, 2003May 20, 2004Frank ButaricStent graft having a pleated graft member
US20050045183 *Jun 28, 2004Mar 3, 2005Ovion, Inc.Methods and devices for occluding body lumens and/or for delivering therapeutic agents
US20050055089 *Jul 19, 2004Mar 10, 2005Ample Medical, Inc.Devices, systems, and methods for reshaping a heart valve annulus
US20050085844 *Dec 24, 2003Apr 21, 2005Ovion, Inc.Contraceptive device and delivery system
US20060041306 *Jul 1, 2005Feb 23, 2006Myocor, Inc.Devices and methods for heart valve treatment
US20060095025 *Aug 1, 2003May 4, 2006The General Hospital CorporationCardiac devices and methods for minimally invasive repair of ischemic mitral regurgitation
USRE34857 *Mar 28, 1994Feb 14, 1995Kunreuther; Steven J.Assembly of attachments and device for attaching same
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7077862 *Jun 15, 2004Jul 18, 2006Myocor, Inc.Devices and methods for heart valve treatment
US7655015Feb 2, 2010Evalve, Inc.Fixation devices, systems and methods for engaging tissue
US7666224Jul 7, 2005Feb 23, 2010Edwards Lifesciences LlcDevices and methods for heart valve treatment
US7670368Mar 2, 2010Boston Scientific Scimed, Inc.Venous valve apparatus, system, and method
US7678145Jul 1, 2005Mar 16, 2010Edwards Lifesciences LlcDevices and methods for heart valve treatment
US7682385Jul 3, 2006Mar 23, 2010Boston Scientific CorporationArtificial valve
US7722666Apr 15, 2005May 25, 2010Boston Scientific Scimed, Inc.Valve apparatus, system and method
US7736388Jan 16, 2007Jun 15, 2010Evalve, Inc.Fixation devices, systems and methods for engaging tissue
US7753923Aug 25, 2004Jul 13, 2010Evalve, Inc.Leaflet suturing
US7766812Apr 14, 2006Aug 3, 2010Edwards Lifesciences LlcMethods and devices for improving mitral valve function
US7776053Dec 12, 2006Aug 17, 2010Boston Scientific Scimed, Inc.Implantable valve system
US7780627Aug 24, 2010Boston Scientific Scimed, Inc.Valve treatment catheter and methods
US7780722Aug 24, 2010Boston Scientific Scimed, Inc.Venous valve apparatus, system, and method
US7799038Jan 20, 2006Sep 21, 2010Boston Scientific Scimed, Inc.Translumenal apparatus, system, and method
US7811296Oct 12, 2010Evalve, Inc.Fixation devices for variation in engagement of tissue
US7842085Sep 1, 2006Nov 30, 2010Vaso AdzichAnnuloplasty ring and holder combination
US7854755Dec 21, 2010Boston Scientific Scimed, Inc.Vascular catheter, system, and method
US7854761Dec 19, 2003Dec 21, 2010Boston Scientific Scimed, Inc.Methods for venous valve replacement with a catheter
US7867274Jan 11, 2011Boston Scientific Scimed, Inc.Valve apparatus, system and method
US7892276Feb 22, 2011Boston Scientific Scimed, Inc.Valve with delayed leaflet deployment
US7904179 *Mar 8, 2011Medtronic, Inc.Implantable medical device system with fixation member
US7951189Jul 27, 2009May 31, 2011Boston Scientific Scimed, Inc.Venous valve, system, and method with sinus pocket
US7959673Jun 14, 2011Edwards Lifesciences CorporationDegenerative valvular disease specific annuloplasty rings
US7967853Jun 28, 2011Boston Scientific Scimed, Inc.Percutaneous valve, system and method
US7975700Feb 7, 2006Jul 12, 2011Koninklijke Philips Electronics N.V.System for adjustable tissue anchors
US7981123Feb 3, 2010Jul 19, 2011Evalve, Inc.Surgical device for connecting soft tissue
US7981139Jul 19, 2011Evalve, IncSuture anchors and methods of use
US7992567Aug 9, 2011Koninklijke Philips Electronics N.V.System and method for percutaneous glossoplasty
US7993396Sep 21, 2009Aug 9, 2011Edwards Lifesciences CorporationMitral valve annuloplasty ring having an offset posterior bow
US7998151Aug 16, 2011Evalve, Inc.Leaflet suturing
US8002824Jul 23, 2009Aug 23, 2011Boston Scientific Scimed, Inc.Cardiac valve, system, and method
US8012198Sep 6, 2011Boston Scientific Scimed, Inc.Venous valve, system, and method
US8029518Oct 30, 2007Oct 4, 2011Evalve, Inc.Methods and devices for capturing and fixing leaflets in valve repair
US8052592Oct 7, 2009Nov 8, 2011Evalve, Inc.Methods and devices for tissue grasping and assessment
US8057493Dec 18, 2009Nov 15, 2011Evalve, Inc.Fixation devices, systems and methods for engaging tissue
US8123703Feb 3, 2010Feb 28, 2012Evalve, Inc.Steerable access sheath and methods of use
US8128681Dec 19, 2003Mar 6, 2012Boston Scientific Scimed, Inc.Venous valve apparatus, system, and method
US8133270Jan 8, 2008Mar 13, 2012California Institute Of TechnologyIn-situ formation of a valve
US8137394Jan 14, 2011Mar 20, 2012Boston Scientific Scimed, Inc.Valve with delayed leaflet deployment
US8142495May 15, 2007Mar 27, 2012Edwards Lifesciences AgSystem and a method for altering the geometry of the heart
US8152844May 7, 2009Apr 10, 2012Edwards Lifesciences CorporationQuick-release annuloplasty ring holder
US8187299Oct 29, 2007May 29, 2012Evalve, Inc.Methods and apparatus for cardiac valve repair
US8197464Jun 12, 2012Cordis CorporationDeflecting guide catheter for use in a minimally invasive medical procedure for the treatment of mitral valve regurgitation
US8216256Feb 26, 2009Jul 10, 2012Evalve, Inc.Detachment mechanism for implantable fixation devices
US8216304May 24, 2010Jul 10, 2012Edwards Lifesciences CorporationAnnuloplasty ring and holder combination
US8226709Jul 24, 2012Cordis CorporationMethod and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation
US8226711Jul 24, 2012Edwards Lifesciences, LlcValve to myocardium tension members device and method
US8236050Dec 18, 2007Aug 7, 2012Edwards Lifesciences CorporationMitral annuloplasty ring having upward bows
US8262675Oct 29, 2008Sep 11, 2012Ethicon Endo-Surgery, Inc.Methods and devices for applying multiple suture anchors
US8262724 *Jun 9, 2009Sep 11, 2012Medtronic Corevalve, Inc.Apparatus for treating a heart valve, in particular a mitral valve
US8287591Sep 19, 2008Oct 16, 2012Edwards Lifesciences CorporationTransformable annuloplasty ring configured to receive a percutaneous prosthetic heart valve implantation
US8343174Jan 1, 2013Evalve, Inc.Locking mechanisms for fixation devices and methods of engaging tissue
US8348999Jan 8, 2013California Institute Of TechnologyIn-situ formation of a valve
US8382828Feb 26, 2013Edwards Lifesciences CorporationMitral annuloplasty rings
US8409273Apr 2, 2013Abbott Vascular IncMulti-catheter steerable guiding system and methods of use
US8414641Apr 9, 2013Boston Scientific Scimed, Inc.Valve with delayed leaflet deployment
US8449608May 28, 2013Edwards Lifesciences CorporationTricuspid ring
US8459524Jun 11, 2010Jun 11, 2013Covidien LpTissue fastening system for a medical device
US8460365Jun 11, 2013Boston Scientific Scimed, Inc.Venous valve, system, and method with sinus pocket
US8470023Jun 22, 2011Jun 25, 2013Boston Scientific Scimed, Inc.Percutaneous valve, system, and method
US8470028Jan 19, 2010Jun 25, 2013Evalve, Inc.Methods, systems and devices for cardiac valve repair
US8480686Sep 25, 2008Jul 9, 2013Ethicon Endo-Surgery, Inc.Methods and devices for delivering and applying suture anchors
US8500761Dec 11, 2009Aug 6, 2013Abbott VascularFixation devices, systems and methods for engaging tissue
US8512399Dec 28, 2009Aug 20, 2013Boston Scientific Scimed, Inc.Valve apparatus, system and method
US8529620Apr 29, 2008Sep 10, 2013Ottavio AlfieriInwardly-bowed tricuspid annuloplasty ring
US8529621Mar 9, 2012Sep 10, 2013Edwards Lifesciences CorporationMethods of repairing an abnormal mitral valve
US8568473Dec 15, 2006Oct 29, 2013Georgia Tech Research CorporationSystems and methods for enabling heart valve replacement
US8568476Mar 22, 2012Oct 29, 2013Edwards Lifesciences CorporationMethods of assembling and delivering a cardiac implant
US8591576Feb 14, 2012Nov 26, 2013Edwards Lifesciences AgMethod for altering the geometry of the heart
US8632585Aug 10, 2012Jan 21, 2014Medtronic Corevalve, Inc.Apparatus for treating a heart valve, in particular a mitral valve
US8672997Apr 24, 2012Mar 18, 2014Boston Scientific Scimed, Inc.Valve with sinus
US8685083Jun 26, 2006Apr 1, 2014Edwards Lifesciences CorporationApparatus, system, and method for treatment of posterior leaflet prolapse
US8721717Jan 27, 2012May 13, 2014Boston Scientific Scimed, Inc.Venous valve apparatus, system, and method
US8734505Sep 24, 2009May 27, 2014Evalve, Inc.Methods and apparatus for cardiac valve repair
US8740918Jun 9, 2011Jun 3, 2014Evalve, Inc.Surgical device for connecting soft tissue
US8740920May 22, 2013Jun 3, 2014Evalve, Inc.Fixation devices, systems and methods for engaging tissue
US8764821Mar 16, 2012Jul 1, 2014Edwards Lifesciences CorporationDegenerative vavlular disease specific annuloplasty ring sets
US8828079Jul 26, 2007Sep 9, 2014Boston Scientific Scimed, Inc.Circulatory valve, system and method
US8858623 *Nov 1, 2012Oct 14, 2014Valtech Cardio, Ltd.Implant having multiple rotational assemblies
US8900295Sep 25, 2012Dec 2, 2014Edwards Lifesciences CorporationProsthetic valve with ventricular tethers
US8915960Aug 30, 2011Dec 23, 2014Edwards Lifesciences CorporationPhysiologic tricuspid annuloplasty ring
US8926695Dec 5, 2007Jan 6, 2015Valtech Cardio, Ltd.Segmented ring placement
US8932349Aug 22, 2011Jan 13, 2015Boston Scientific Scimed, Inc.Cardiac valve, system, and method
US8932350Nov 28, 2011Jan 13, 2015Edwards Lifesciences CorporationReduced dehiscence annuloplasty ring
US8961538Mar 3, 2009Feb 24, 2015Arthrex, Inc.Method and system for meniscal repair using suture implant cinch construct
US9011529Apr 27, 2011Apr 21, 2015Edwards Lifesciences CorporationMitral annuloplasty rings with sewing cuff
US9011531Feb 13, 2013Apr 21, 2015Mitraspan, Inc.Method and apparatus for repairing a mitral valve
US9028542Sep 6, 2011May 12, 2015Boston Scientific Scimed, Inc.Venous valve, system, and method
US9044246Aug 24, 2011Jun 2, 2015Abbott Vascular Inc.Methods and devices for capturing and fixing leaflets in valve repair
US9060858May 28, 2013Jun 23, 2015Evalve, Inc.Methods, systems and devices for cardiac valve repair
US9078749Aug 21, 2014Jul 14, 2015Georg LutterTruncated cone heart valve stent
US9089320Sep 25, 2008Jul 28, 2015Ethicon Endo-Surgery, Inc.Methods and devices for delivering and applying multiple suture anchors
US9095433Oct 18, 2011Aug 4, 2015Georg LutterTruncated cone heart valve stent
US9101472Feb 7, 2013Aug 11, 2015Edwards Lifesciences CorporationActive holder for annuloplasty ring delivery
US9119719Jan 24, 2013Sep 1, 2015Valtech Cardio, Ltd.Annuloplasty ring with intra-ring anchoring
US9125742Dec 15, 2006Sep 8, 2015Georgia Tech Research FoundationPapillary muscle position control devices, systems, and methods
US9149359Feb 9, 2012Oct 6, 2015Edwards Lifesciences CorporationThree-dimensional annuloplasty ring
US9155620Jun 15, 2009Oct 13, 2015Valtec Cardio, Ltd.Annuloplasty devices and methods of delivery therefor
US9192472Jun 15, 2009Nov 24, 2015Valtec Cardio, Ltd.Annuloplasty devices and methods of delivery therefor
US9198757Jul 7, 2009Dec 1, 2015Edwards Lifesciences, LlcMethods and devices for improving mitral valve function
US9204965 *Jan 14, 2009Dec 8, 2015Lc Therapeutics, Inc.Synthetic chord
US9254192Jun 22, 2015Feb 9, 2016Georg LutterTruncated cone heart valve stent
US9265608Sep 15, 2014Feb 23, 2016Valtech Cardio, Ltd.Implant having multiple rotational assemblies
US9271834 *Sep 5, 2013Mar 1, 2016Suntech Co., LtdSheath and cerclage thread for mitral cerclage annuloplasty
US9289580 *Jan 29, 2014Mar 22, 2016James E. ColemanGastric bypass devices and procedures
US9301843Nov 10, 2010Apr 5, 2016Boston Scientific Scimed, Inc.Venous valve apparatus, system, and method
US9326858Feb 5, 2013May 3, 2016Edwards Lifesciences CorporationFlexible annuloplasty ring
US20040039442 *Aug 7, 2003Feb 26, 2004Evalve, Inc.Methods and apparatus for cardiac valve repair
US20040049207 *May 19, 2003Mar 11, 2004Evalve, Inc., A Delaware CorporationFixation device and methods for engaging tissue
US20040148020 *Nov 10, 2003Jul 29, 2004Vidlund Robert M.Devices and methods for heart valve treatment
US20040215339 *Oct 23, 2003Oct 28, 2004Drasler William J.Venous valve apparatus and method
US20040243229 *Jun 15, 2004Dec 2, 2004Myocor, Inc.Devices and methods for heart valve treatment
US20050021057 *Aug 25, 2004Jan 27, 2005Evalve, Inc.Leaflet structuring
US20050075723 *May 7, 2004Apr 7, 2005Myocor, Inc.Methods and devices for improving mitral valve function
US20050085723 *Oct 4, 2004Apr 21, 2005Joel HuebnerRadiolucent medical devices with radiopaque markers
US20060020275 *May 16, 2005Jan 26, 2006Evalve, Inc.Locking mechanisms for fixation devices and methods of engaging tissue
US20060036317 *Jul 7, 2005Feb 16, 2006Myocor, Inc.Decives and methods for heart valve treatment
US20060041306 *Jul 1, 2005Feb 23, 2006Myocor, Inc.Devices and methods for heart valve treatment
US20060052868 *Jul 1, 2005Mar 9, 2006Myocor, Inc.Valve to myocardium tension members device and method
US20060085066 *Dec 7, 2005Apr 20, 2006Boston Scientific CorporationBody lumen closure
US20060149123 *Mar 7, 2006Jul 6, 2006Myocor, Inc.Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly
US20060161040 *Dec 23, 2005Jul 20, 2006Myocor, Inc.Methods and devices for improving cardiac function in hearts
US20060173490 *Feb 1, 2005Aug 3, 2006Boston Scientific Scimed, Inc.Filter system and method
US20060178729 *Feb 7, 2005Aug 10, 2006Boston Scientific Scimed, Inc.Venous valve apparatus, system, and method
US20060178730 *Feb 7, 2005Aug 10, 2006Boston Scientific Scimed, Inc.Venous valve apparatus, system, and method
US20060184203 *Apr 11, 2006Aug 17, 2006Evalve, Inc.Suture anchors and methods of use
US20060190074 *Feb 23, 2005Aug 24, 2006Boston Scientific Scimed, Inc.Valve apparatus, system and method
US20060195012 *Apr 14, 2006Aug 31, 2006Myocor, Inc.Valve to myocardium tension members device and method
US20060229708 *Feb 7, 2006Oct 12, 2006Powell Ferolyn TMethods, systems and devices for cardiac valve repair
US20060235509 *Apr 15, 2005Oct 19, 2006Boston Scientific Scimed, Inc.Valve apparatus, system and method
US20060241340 *Apr 14, 2006Oct 26, 2006Myocor, Inc.Methods and devices for improving mitral valve function
US20060247672 *Apr 27, 2005Nov 2, 2006Vidlund Robert MDevices and methods for pericardial access
US20060253189 *Jul 3, 2006Nov 9, 2006Boston Scientific CorporationArtificial valve
US20060282157 *Jun 10, 2005Dec 14, 2006Hill Jason PVenous valve, system, and method
US20070067021 *Sep 21, 2005Mar 22, 2007Boston Scientific Scimed, Inc.Venous valve, system, and method with sinus pocket
US20070118155 *Jan 16, 2007May 24, 2007Evalve, Inc.Fixation devices, systems and methods for engaging tissue
US20070123979 *Jun 26, 2006May 31, 2007Patrick PerierApparatus, system, and method for treatment of posterior leaflet prolapse
US20070129737 *Jan 16, 2007Jun 7, 2007Evalve, Inc.Fixation devices, systems and methods for engaging tissue
US20070129788 *Jan 11, 2007Jun 7, 2007Boston Scientific Scimed, Inc.Venous valve with sinus
US20070156234 *Sep 1, 2006Jul 5, 2007Vaso AdzichApparatus, system, and method for delivering an annuloplasty ring
US20070173930 *Jan 20, 2006Jul 26, 2007Boston Scientific Scimed, Inc.Translumenal apparatus, system, and method
US20080051807 *Oct 29, 2007Feb 28, 2008Evalve, Inc.Methods and apparatus for cardiac valve repair
US20080097489 *Dec 21, 2007Apr 24, 2008Evalve, Inc.Fixation devices, systems and methods for engaging tissue
US20080097593 *Dec 18, 2007Apr 24, 2008Bolling Steven FMitral Annuloplasty Ring Having Upward Bows
US20080126131 *Jul 17, 2006May 29, 2008Walgreen Co.Predictive Modeling And Risk Stratification Of A Medication Therapy Regimen
US20080167714 *Mar 24, 2008Jul 10, 2008Evalve, Inc.Methods and apparatus for cardiac valve repair
US20080183194 *Oct 30, 2007Jul 31, 2008Evalve, Inc.Methods and devices for capturing and fixing leaflets in valve repair
US20080208303 *Feb 28, 2008Aug 28, 2008Rutten Jean J GImplantable medical device system with fixation member
US20080208339 *Feb 28, 2008Aug 28, 2008Rutten Jean J GImplantable medical device system with fixation member
US20080215072 *Jan 21, 2008Sep 4, 2008Graham KellyMethods and apparatus for utilization of barbed sutures in human tissue including a method for eliminating or improving blood flow in veins
US20080262609 *Dec 5, 2007Oct 23, 2008Valtech Cardio, Ltd.Segmented ring placement
US20080269877 *Feb 5, 2008Oct 30, 2008Jenson Mark LSystems and methods for valve delivery
US20080275551 *Apr 29, 2008Nov 6, 2008Edwards Lifesciences CorporationInwardly-bowed tricuspid annuloplasty ring
US20080300678 *Feb 5, 2008Dec 4, 2008Eidenschink Tracee E JPercutaneous valve, system and method
US20090030512 *Jul 26, 2007Jan 29, 2009Thielen Joseph MCirculatory valve, system and method
US20090082619 *Dec 2, 2008Mar 26, 2009De Marchena EduardoMethod of treating cardiomyopathy
US20090105815 *Oct 10, 2008Apr 23, 2009Matthew KreverPush-in retainer system for use in the direct plication annuloplasty treatment of mitral valve regurgitation
US20090105816 *Oct 10, 2008Apr 23, 2009Olsen Daniel HSystem using a helical retainer in the direct plication annuloplasty treatment of mitral valve regurgitation
US20090164029 *Dec 21, 2007Jun 25, 2009Boston Scientific Scimed, Inc.Valve with delayed leaflet deployment
US20090171456 *Dec 28, 2007Jul 2, 2009Kveen Graig LPercutaneous heart valve, system, and method
US20090177276 *Sep 11, 2008Jul 9, 2009Edwards Lifesciences CorporationDegenerative Valvular Disease Specific Annuloplasty Rings
US20090228042 *Mar 3, 2009Sep 10, 2009Koogle Jr David CMethod and system for meniscal repair using suture implant cinch construct
US20090247826 *Feb 3, 2009Oct 1, 2009Olympus CorporationTube for endoscope
US20090270980 *Jul 7, 2009Oct 29, 2009Edwards Lifesciences LlcMethods and Devices for Improving Mitral Valve Function
US20090326567 *Dec 31, 2009Evalve, Inc.Locking mechanisms for fixation devices and methods of engaging tissue
US20100010625 *Jan 14, 2010Edwards Lifesciences CorporationMitral valve annuloplasty ring having an offset posterior bow
US20100016958 *Jan 21, 2010Evalve, Inc.Methods and apparatus for cardiac valve repair
US20100022823 *Jan 28, 2010Evalve, Inc.Methods and devices for tissue grasping and assessment
US20100030328 *Feb 4, 2010Medtronic, Inc.Apparatus for Treating a Heart Valve, in Particular a Mitral Valve
US20100063586 *May 15, 2007Mar 11, 2010John Michael HasenkamSystem and a method for altering the geometry of the heart
US20100076408 *Dec 22, 2008Mar 25, 2010Matthew KreverDeflecting guide catheter for use in a minimally invasive medical procedure for the treatment of mitral valve regurgitation
US20100076462 *Mar 25, 2010Ethicon Endo-Surgery, Inc.Methods and devices for delivering and applying suture anchors
US20100076488 *Mar 25, 2010Ethicon Endo-Surgery, Inc.Methods and devices for delivering and applying multiple suture anchors
US20100076549 *Mar 25, 2010Edwards Lifesciences CorporationAnnuloplasty Ring Configured to Receive a Percutaneous Prosthetic Heart Valve Implantation
US20100100108 *Dec 18, 2009Apr 22, 2010Evalve, Inc.Fixation devices, systems and methods for engaging tissue
US20100100173 *Dec 28, 2009Apr 22, 2010Boston Scientific Scimed, Inc.Valve apparatus, system and method
US20100106166 *Oct 29, 2008Apr 29, 2010Ethicon Endo-Surgery, Inc.Methods and devices for applying mulitple suture anchors
US20100137980 *Feb 1, 2010Jun 3, 2010Edwards Lifesciences CorporationAnnular Prosthesis for a Mitral Valve
US20100152793 *Nov 11, 2009Jun 17, 2010David LowryTranscorporeal spinal decompression and repair systems and related methods
US20100179574 *Jul 15, 2010James LongoriaSynthetic chord
US20100185278 *Jan 21, 2010Jul 22, 2010Tendyne MedicalApical Papillary Msucle Attachment for Left Ventricular Reduction
US20100191256 *Feb 3, 2010Jul 29, 2010Evalve, Inc.Surgical device for connecting soft tissue
US20100210899 *Mar 29, 2010Aug 19, 2010Tendyne Medical, Inc.Method for percutaneous lateral access to the left ventricle for treatment of mitral insufficiency by papillary muscle alignment
US20100217283 *May 4, 2010Aug 26, 2010Evalve,Inc.Leaflet suturing
US20110004296 *Sep 10, 2008Jan 6, 2011Georg LutterHeart Valve Stent
US20110015476 *Jan 20, 2011Jeff FrancoDevices and Methods for Treating Cardiomyopathy
US20110015727 *May 24, 2010Jan 20, 2011Edwards Lifesciences CorporationAnnuloplasty Ring and Holder Combination
US20110034999 *Feb 10, 2011Edwards Lifesciences CorporationDegenerative valvular disease specific annuloplasty rings
US20110036888 *Jun 11, 2010Feb 17, 2011Tyco Healthcare Group LpTissue fastening system for a medical device
US20110060405 *Nov 10, 2010Mar 10, 2011Boston Scientific Scimed, Inc.Venous valve apparatus, system, and method
US20110066233 *Mar 17, 2011Thornton Troy LMethods, systems and devices for cardiac valve repair
US20110071625 *Mar 24, 2011Boston Scientific Scimed, Inc.Valve apparatus, system and method
US20110118831 *May 19, 2011Boston Scientific Scimed, Inc.Valve with delayed leaflet deployment
US20110160849 *Jun 30, 2011Edwards Lifesciences CorporationBimodal tricuspid annuloplasty ring
US20110166649 *Jun 15, 2009Jul 7, 2011Valtech Cardio Ltd.Annuloplasty devices and methods of deliver therefor
US20110184511 *Jul 28, 2011Edwards Lifesciences CorporationTricuspid ring
US20110230949 *Sep 22, 2011Boston Scientific Scimed, Inc.Venous Valve, System, and Method With Sinus Pocket
US20110238165 *Sep 29, 2011Evalve, Inc.Surgical device for connecting soft tissue
US20130116780 *Nov 1, 2012May 9, 2013Valtech Cardio, Ltd.Implant having multiple rotational assemblies
US20140067051 *Sep 5, 2013Mar 6, 2014Suntech Co.Sheath and cerclage thread for mitral cerclage annuloplasty
US20140221900 *Jan 29, 2014Aug 7, 2014Christy CumminsGastric bypass devices and procedures
EP2098172A1 *Mar 3, 2009Sep 9, 2009Arthrex, Inc.System for meniscal repair using suture implant cinch construct
EP2283783A1 *Aug 13, 2010Feb 16, 2011Tyco Healthcare Group LPTissue fastening system for a medical device
EP2381852A2 *Jan 21, 2010Nov 2, 2011Tendyne Medical, Inc.Apical papillary muscle attachment for left ventricular reduction
EP2506777A1 *Dec 2, 2010Oct 10, 2012Valtech Cardio, Ltd.Delivery tool for implantation of spool assembly coupled to a helical anchor
WO2008081256A1 *Dec 18, 2007Jul 10, 2008Medtronic Corevalve LlcMaterial for treatment of a heart valve, in particular a mitral valve
WO2008129405A2 *Apr 14, 2008Oct 30, 2008Medtronic Corevalve Llc.Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
WO2008129405A3 *Apr 14, 2008Jan 29, 2009Corevalve IncImplant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
WO2010036566A1 *Sep 18, 2009Apr 1, 2010Ethicon Endo-Surgery, Inc.Methods and devices for delivering and applying multiple suture anchors
WO2015020816A1 *Jul 25, 2014Feb 12, 2015Lc Therapeutics, Inc.Synthetic chord for cardiac valve repair applications
Classifications
U.S. Classification606/232
International ClassificationA61B17/04
Cooperative ClassificationA61B2017/0441, A61F2/2487, A61B17/0401, A61B2017/00783, A61B17/06061, A61B17/00234, A61B2017/0496, A61B2017/0475, A61B2017/0472, A61B2017/0409, A61B2017/06057, A61F2/2445, A61F2/2454, A61B2017/0649, A61B17/068, A61B17/0483, A61B2017/00243
European ClassificationA61F2/24W4, A61B17/04A, A61B17/00E, A61B17/04H, A61F2/24R2